Instaryl LS Junior Expectorant is a pediatric formulation combining Levosalbutamol (0.5mg/5ml), Ambroxol (15mg/5ml), and Guaifenesin (50mg/5ml) designed to provide comprehensive relief from respiratory conditions characterized by bronchospasm and excessive mucus production. Levosalbutamol, a selective β2-adrenergic receptor agonist, acts as a bronchodilator to alleviate bronchoconstriction, thereby improving airflow and easing breathing difficulties in children. Ambroxol serves as a mucolytic agent that facilitates the breakdown and clearance of viscous mucus from the respiratory tract, enhancing expectoration and reducing cough severity. Guaifenesin, an expectorant, promotes the hydration of airway secretions, making mucus less sticky and easier to expel. The synergistic action of these active ingredients helps in the effective management of conditions such as bronchitis, asthma, and other obstructive airway diseases with productive cough. Instaryl LS Junior Expectorant is formulated for oral administration and is suitable for pediatric patients requiring symptomatic relief from cough and bronchospasm. It is recommended to use under medical supervision, with dosage adjusted according to age and severity of symptoms. Caution is advised in patients with hypersensitivity to any component or underlying cardiac disorders.